Abetalipoproteinemia is a rare inherited disorder in which the body cannot properly absorb fats and fat-soluble vitamins from food. It is caused by mutations in a gene that helps package and transport dietary fats out of the intestines and liver into the bloodstream. Without treatment, it leads to serious nutritional deficiencies that can damage the eyes, nervous system, and blood cells. Symptoms typically appear in infancy, and the condition affects fewer than 1 in 100,000 people worldwide.
How the Condition Works
The problem centers on a protein called microsomal triglyceride transfer protein, or MTP. This protein works inside the cells lining your intestines and liver, where its job is to load fats onto carrier molecules (lipoproteins) so they can be shipped into the bloodstream. Think of MTP as the loading dock worker that packages fats for delivery to the rest of your body.
In abetalipoproteinemia, mutations in the gene that codes for MTP (called MTTP, located on chromosome 4) produce a protein that either doesn’t fold correctly or doesn’t function at all. Lab studies of one such mutation found that cells expressing the defective protein had negligible levels of MTP activity. Without a working version of this protein, the body cannot assemble or secrete the lipoproteins that carry cholesterol and triglycerides through the blood. The result: fats accumulate in intestinal and liver cells instead of reaching the tissues that need them.
The condition follows an autosomal recessive inheritance pattern, meaning a child must inherit a defective copy of the gene from both parents to develop symptoms. Parents who each carry one mutated copy typically have no symptoms themselves.
Early Signs in Infancy
Symptoms usually appear shortly after an infant begins feeding, particularly after the introduction of breast milk or formula containing fat. The hallmark early signs include fatty, foul-smelling stools (steatorrhea), diarrhea, vomiting, and failure to gain weight and grow at the expected rate. These symptoms occur because unabsorbed fat passes straight through the digestive tract instead of being taken up into the body.
Infants may also develop a distended abdomen and show general signs of malnutrition despite apparently adequate feeding. Because the symptoms overlap with more common conditions like cow’s milk protein intolerance or celiac disease, abetalipoproteinemia can be missed early on if blood work isn’t checked.
How It Affects the Blood
A fasting lipid panel in someone with abetalipoproteinemia reveals strikingly low numbers. Total cholesterol often falls below 30 mg/dL (a typical adult range is 150 to 200 mg/dL), and LDL cholesterol and triglycerides are essentially undetectable. These extremely low lipid levels are one of the strongest diagnostic clues.
The condition also changes the shape of red blood cells. Under a microscope, a blood smear shows cells called acanthocytes, sometimes referred to as spur cells. These are red blood cells with irregular, thorn-like projections sticking out from their surface at uneven intervals. The abnormal shape occurs because the cell membranes don’t get the right balance of fats and cholesterol. Acanthocytes are fragile and can break down faster than normal, sometimes contributing to mild anemia.
Neurological and Vision Complications
The most serious long-term consequences of abetalipoproteinemia come from the inability to absorb fat-soluble vitamins, particularly vitamins A and E. These vitamins are critical for maintaining healthy nerve tissue and retinal function, and without them, progressive damage accumulates over years.
Vitamin E deficiency is especially damaging to the nervous system. Over time, affected individuals can develop problems with balance and coordination (ataxia), loss of sensation in the hands and feet from peripheral nerve damage, and muscle weakness. These neurological symptoms may begin in childhood or adolescence and worsen if left untreated.
Vision problems stem largely from vitamin A deficiency. The retina depends on vitamin A to function, and prolonged deficiency leads to a condition resembling retinitis pigmentosa, where the light-sensing cells in the back of the eye gradually deteriorate. Early symptoms include difficulty seeing in low light (night blindness), which can progress to significant vision loss. Vitamin K deficiency can also cause easy bruising or prolonged bleeding, since this vitamin is essential for normal blood clotting.
How It Is Diagnosed
Abetalipoproteinemia is typically suspected in an infant with persistent steatorrhea, vomiting, and failure to thrive. The diagnosis comes together through a combination of blood tests and clinical findings. Extremely low plasma cholesterol, absent or near-absent LDL and VLDL levels, and acanthocytes on a blood smear form the classic diagnostic picture. Genetic testing of the MTTP gene can confirm the diagnosis definitively.
It’s worth noting that a similar-looking condition called familial hypobetalipoproteinemia (FHBL) can cause confusion. FHBL is caused by mutations in a different gene (the one encoding apolipoprotein B itself, or sometimes PCSK9) and follows a codominant inheritance pattern, meaning even carriers with one mutated copy tend to have low LDL levels, typically between 20 and 50 mg/dL. In abetalipoproteinemia, LDL is undetectable rather than just low, and parents of affected children usually have completely normal lipid levels. This distinction helps clinicians tell the two conditions apart.
Treatment and Daily Management
There is no cure for abetalipoproteinemia, but early and consistent treatment can prevent or significantly slow the most serious complications. Management revolves around two strategies: adjusting the diet and supplementing the vitamins the body can’t absorb on its own.
Because the body can’t process regular dietary fats (long-chain triglycerides), people with this condition follow a diet that restricts conventional fat intake. Instead, they use medium-chain triglyceride (MCT) oil as a calorie source. MCT oil is unique because medium-chain fats can be absorbed directly into the bloodstream from the intestine without needing to be packaged into lipoproteins first. This bypasses the exact step that’s broken in abetalipoproteinemia, allowing the body to get the energy it needs from fat without the GI symptoms.
High-dose fat-soluble vitamin supplementation is the other cornerstone of treatment. Vitamins A, D, E, and K are all given in doses well above what a typical person would take, because absorption remains poor even with dietary modifications. Vitamin E supplementation is considered the most critical, since the neurological damage it prevents is largely irreversible once it occurs. The specific doses are tailored by a specialist and adjusted over time based on blood levels and clinical response.
Long-Term Outlook
The prognosis for abetalipoproteinemia depends heavily on how early treatment begins. Children who start vitamin supplementation and dietary management in infancy have the best chance of avoiding the severe neurological and visual complications that define untreated disease. With consistent treatment, many individuals maintain relatively normal neurological function and vision well into adulthood.
Without treatment, the outlook is much worse. Progressive nerve damage, loss of coordination, and significant vision impairment typically develop by adolescence or early adulthood. Because the condition is so rare, long-term data on large groups of patients is limited, but case reports consistently show that early intervention makes a meaningful difference in quality of life. Lifelong monitoring of vitamin levels, liver function, and neurological status remains important regardless of how well symptoms are controlled.